Ads by Google

Drug Clinical Trials

Penwest Begins Dosing Phase IIa Clinical Study Of Nalbuphine ER

Penwest Pharmaceuticals has begun dosing patients in its Phase IIa study to evaluate the analgesic efficacy of nalbuphine hydrochloride extended release tablet formulation (nalbuphine ER), a product the Company is developing for the treatment of chronic pain.

Health and Wellness: 

Vical Demonstrates Safety And Tolerability Of IL-2 DNA Delivery With Electroporation

Vical Incorporated announced data from an ongoing Phase 1 clinical trial demonstrated that intratumoral delivery of plasmid DNA encoding interleukin-2 into melanoma tumors, followed by electroporation, was administered safely following sedative premedication.

Health and Wellness: 

Positive Intermediate Phase I Results For Inhaled Alpha-1 Antitrypsin

The first of two stages of the Phase I clinical trial show positive results for Kamada's Alpha-1 Antitrypsin liquid drug candidate for inhalation delivered with PARI's eFlow electronic nebulizer for the treatment of patients suffering from AAT deficiency.

Health and Wellness: 

Pages